Bank of New York Mellon
DXTR

Bank of New York Mellon’s Dextera Surgical Inc. DXTR Stock Holding History

Bank of New York Mellon’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-61,920
Closed -$17K – 4445
2017
Q3 		$17K Buy
61,920
+12,499
+25% +$3.6K ﹤0.01% 4226
2017
Q2 		$15K Buy
+49,421
New +$25K ﹤0.01% 4250

Other funds holding DXTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Bank of New York Mellon's DXTR Position: Q4 2017 in Review

Bank of New York Mellon sold out of Dextera Surgical Inc. (DXTR) in Q4 2017, closing a stake of 61,920 shares — an estimated $17K sold.

Bank of New York Mellon first reported a position in DXTR in Q2 2017 and held it in 2 quarters. The position peaked at $17K in Q3 2017. 3 funds tracked by Wall St. Rank hold DXTR as of Q4 2017.

  • Bank of New York Mellon reported no remaining Dextera Surgical Inc. position as of Q4 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 61,920 Dextera Surgical Inc. shares in Q4 2017, an estimated $17K.
  • Bank of New York Mellon first reported a position in Dextera Surgical Inc. in Q2 2017 and held it in 2 quarters.
  • Bank of New York Mellon's Dextera Surgical Inc. position peaked at $17K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q4 2017.

Based on Bank of New York Mellon's 13F filing for Q4 2017, filed 9 Feb 2018.